TIBA AYNECHI

Profile

First Name

: TIBA

Middle Name

:

Last Name

: AYNECHI

Related Companies
Titles
Company Name
Related People
DIRECTOR
THESAN PHARMACEUTICALS, INC.
METTE AGGER, PETER BISGAARD, GIOVANNI FERRARA, JOHN GORDON FOULKES, ED MONAGHAN, MICHAEL ROSS, HENRY SKINNER, HOWARD WELGUS
DIRECTOR
IRHYTHM TECHNOLOGIES, INC.
SAM E. BRASCH, CASPER DE CLERCQ, MATTHEW GARRETT, MICHAEL GOLDBERG, MICHAEL D. GOLDBERG, CHRIS E. GRANT, JOSHUA L. GREEN, SHELLY D. GUYER, STEVE JOHNSON, ROBERTA KATZ, ROBERTA R. KATZ, KEVIN M. KING, UDAY KUMAR, UDAY N. KUMAR, VIJAY LATHI, VIJAY K. LATHI, JUDITH LENANE, HARDWIN MEAD, R. HARDWIN MEAD, R. HARDWIN MEAD, RAYMOND SCOTT, WILLIAM STARLING, WILLIAM N. STARLING, WILLIAM WILLIS, WILLIAM F. WILLIS
DIRECTOR
ANAPTYSBIO INC
CAROL GALLAGHER, ROBERT HOFFMAN, KEVIN KINSELLA, MARCO LONDEI, HEATH LUKATCH, HEATHE LUKATCH, NICHOLAS LYDON, NICK LYDON, J. LEIGHTON READ, HOLLINGS RENTON, JOHN SCHMID, THOMAS SMART, HAMZA SURIA, JAMES TOPPER, JAMES N. TOPPER
DIRECTOR
GENOA PHARMACEUTICALS, INC.
LYN BARANOWSKI, DANIEL D. BURGESS, JILL CARROLL, SOFIA IOANNIDOU, MICHAEL J. KAMDAR, JONATHAN LEFF, JONATHAN LEFF, M.D., CASSANDRA GIANNA LUCA, ROBERT MITTENDORFF, PETER MOLDT, A. BRUCE MONTGOMERY, BRUCE MONTGOMERY, M.D., NIALL O-DONNELL, KETAN PATEL, HEATHER PRESTON, NAVEED SIDDIQI, MARK W. SURBER, PH.D., RICHARD G. VINCENT
DIRECTOR
MIRUM PHARMACEUTICALS, INC.
ERIC BJERKHOLT, LAURA BREGE, LON CARDON, IAN CLEMENTS, SUSAN DUBE, WILLIAM C. FAIREY, LAURENT FISCHER, MICHAEL GREY, MICHAEL G. GREY, PATRICK HERON, PATRICK J. HERON, JONATHAN LEFF, LARA LONGPRE, ED MATHERS, EDWARD T. MATHERS, NIALL O-DONNELL, CHRIS PEETZ, CHRISTOPHER PEETZ, PETER RADOVICH, SAIRA RAMASASTRY, EDWIN JONATHAN TUCKER, PAMELA VIG, TIMOTHY WALBERT
DIRECTOR
ARCELLX, INC.
HUGO BEEKMAN, ALI BEHBAHANI, JILL CARROLL, RAMI ELGHANDOUR, MICHELLE GILSON, CHRISTOPHER HEERY, DAVID HILBERT, HAN LEE, DAVID LUBNER, KAVITA PATEL, ROGER SAWHNEY, LANCE THIBAULT, OLIVIA WARE, LEWIS T. WILLIAMS, LEWIS T. RUSTY WILLIAMS, DEREK YOON
DIRECTOR
NKARTA, INC.
FOUAD AZZAM, ALI BEHBAHANI, JILL CARROLL, MICHAEL DYBBS, PAUL HASTINGS, MATTHEW PLUNKETT
DIRECTOR
AVALYN PHARMA INC.
LYN BARANOWSKI, DANIEL D. BURGESS, JILL CARROLL, SOFIA IOANNIDOU, MICHAEL J. KAMDAR, JONATHAN LEFF, JONATHAN LEFF, M.D., CASSANDRA GIANNA LUCA, ROBERT MITTENDORFF, PETER MOLDT, A. BRUCE MONTGOMERY, BRUCE MONTGOMERY, M.D., NIALL O-DONNELL, KETAN PATEL, HEATHER PRESTON, NAVEED SIDDIQI, MARK W. SURBER, PH.D., RICHARD G. VINCENT
DIRECTOR
SPRUCE BIOSCIENCES, INC.
PERCIVAL BARRETTO-KO, SIMPSON CAMILLA, RALPH WILLIAM CHARLTON III, DINA CHAYA, SAMIR GHARIB, MICHAEL GREY, JONAS HANSSON, RICHARD KING, BALI MURALIDHAR, NIALL O-DONNELL, CAMILLA SIMPSON, DANIEL SPIEGELMAN, JAVIER SZWARCBERG, KIRK WAYS
DIRECTOR
ARISTEA THERAPEUTICS, INC.
KENNETH HARRISON, CIARA KENNEDY, JAMES MACKAY, LORETTA TSE
DIRECTOR
MBX BIOSCIENCES, INC.
RICHARD BARTRAM, JAMES M. CORNELIUS, RICHARD DIMARCHI, CARL GORDON, PETER KENT HAWRYLUK, PATRICK HERON, TIMOTHY KNICKERBOCKER, EDWARD MATHERS, ORA PESCOVITZ
DIRECTOR
REZO THERAPEUTICS, INC.
VINEETA AGARWALA, SOURAV BANDYOPADHYAY, NORBERT BISCHOFBERGER, JENNIFER CHANG, SIMEON GEORGE, DEREK HICKS, NEVAN KROGAN, NADIR MAHMOOD, GEORGE SCANGOS
DIRECTOR
RAY THERAPEUTICS, INC.
GARY ABRAMS, SEAN AINSWORTH, PAUL BRESGE, RAYMOND CAMAHORT, HANNAH CHANG, CAMERON GALLAGHER, ANDREW HOWARD, DMITRY KUZMIN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-10-17
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2025-10-09 
2025-08-18
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-07-21 
2023-10-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-09-22 
2023-05-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-15 
2023-02-28
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2023-02-16 
2022-12-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-07-21 
2022-11-18
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-07 
2021-08-05
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-06 
2021-07-01
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2021-03-26 
2021-04-09
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2021-03-26 
2020-12-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-12-22 
2020-10-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-06 
2020-08-14
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NOT APPLICABLE 
Equity 
2020-02-19 
2020-05-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-24 
2019-10-15
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-09 
2019-09-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-27 
2019-08-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-09 
2018-11-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-05 
2017-05-24
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-13 
2017-03-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-13 
2015-07-24
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-07-13 
2015-03-16
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-16 
2014-02-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-02-11 
2012-09-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-31